Corrigendum to "Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies" [Biomed. Pharmacother. 150 (2022) 112949].

Biomed Pharmacother

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Engineering Laboratory of Development and Application of Traditional

Published: August 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2023.114944DOI Listing

Publication Analysis

Top Keywords

corrigendum "hyperprogression
4
"hyperprogression challenge
4
challenge pd-1/pd-l1
4
pd-1/pd-l1 inhibitors
4
inhibitors treatments
4
treatments potential
4
potential mechanisms
4
mechanisms coping
4
coping strategies"
4
strategies" [biomed
4

Similar Publications

Corrigendum to "Hyperprogression, a challenge of PD-1/PD-L1 inhibitors treatments: potential mechanisms and coping strategies" [Biomed. Pharmacother. 150 (2022) 112949].

Biomed Pharmacother

August 2023

School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China; Engineering Laboratory of Development and Application of Traditional

View Article and Find Full Text PDF